1,231.41
Netflix Inc stock is traded at $1,231.41, with a volume of 5.31M.
It is up +0.75% in the last 24 hours and up +3.30% over the past month.
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
See More
Previous Close:
$1,222.29
Open:
$1234.45
24h Volume:
5.31M
Relative Volume:
1.25
Market Cap:
$512.23B
Revenue:
$40.17B
Net Income/Loss:
$9.27B
P/E Ratio:
58.20
EPS:
21.16
Net Cash Flow:
$7.45B
1W Performance:
+1.59%
1M Performance:
+3.30%
6M Performance:
+35.46%
1Y Performance:
+81.35%
Netflix Inc Stock (NFLX) Company Profile
Name
Netflix Inc
Sector
Industry
Phone
408-540-3700
Address
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
NFLX
Netflix Inc
|
1,231.41 | 512.23B | 40.17B | 9.27B | 7.45B | 21.16 |
![]()
DIS
Walt Disney Co
|
117.63 | 213.45B | 94.04B | 8.91B | 10.90B | 4.89 |
![]()
LYV
Live Nation Entertainment Inc
|
148.87 | 33.31B | 22.74B | 973.97M | 1.34B | 2.93 |
![]()
WBD
Warner Bros Discovery Inc
|
10.52 | 24.77B | 38.34B | -10.80B | 4.34B | -4.40 |
![]()
FOXA
Fox Corporation
|
55.25 | 24.61B | 15.18B | 2.19B | 1.84B | 4.67 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-12-25 | Reiterated | Oppenheimer | Outperform |
Jun-03-25 | Reiterated | Jefferies | Buy |
May-30-25 | Reiterated | BofA Securities | Buy |
May-19-25 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-21-25 | Reiterated | BMO Capital Markets | Outperform |
Apr-21-25 | Reiterated | Barclays | Equal Weight |
Apr-21-25 | Reiterated | Canaccord Genuity | Buy |
Apr-21-25 | Reiterated | Guggenheim | Buy |
Apr-21-25 | Reiterated | JP Morgan | Overweight |
Apr-21-25 | Reiterated | KeyBanc Capital Markets | Overweight |
Apr-21-25 | Reiterated | MoffettNathanson | Buy |
Apr-21-25 | Reiterated | Morgan Stanley | Overweight |
Apr-21-25 | Reiterated | Oppenheimer | Outperform |
Apr-21-25 | Reiterated | Piper Sandler | Overweight |
Apr-21-25 | Reiterated | Pivotal Research Group | Buy |
Apr-21-25 | Reiterated | Wells Fargo | Overweight |
Apr-17-25 | Resumed | Piper Sandler | Overweight |
Mar-27-25 | Initiated | FBN Securities | Outperform |
Mar-17-25 | Upgrade | MoffettNathanson | Neutral → Buy |
Jan-24-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
Jan-23-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Jan-22-25 | Upgrade | Barclays | Underweight → Equal Weight |
Jan-22-25 | Upgrade | Canaccord Genuity | Hold → Buy |
Jan-22-25 | Reiterated | Oppenheimer | Outperform |
Jan-22-25 | Reiterated | Pivotal Research Group | Buy |
Jan-22-25 | Upgrade | Rosenblatt | Neutral → Buy |
Jan-22-25 | Upgrade | The Benchmark Company | Sell → Hold |
Jan-16-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
Jan-15-25 | Reiterated | BMO Capital Markets | Outperform |
Jan-15-25 | Reiterated | Oppenheimer | Outperform |
Jan-08-25 | Reiterated | Goldman | Neutral |
Jan-06-25 | Reiterated | Argus | Buy |
Jan-03-25 | Reiterated | The Benchmark Company | Sell |
Dec-19-24 | Reiterated | UBS | Buy |
Dec-16-24 | Downgrade | Loop Capital | Buy → Hold |
Dec-16-24 | Reiterated | Oppenheimer | Outperform |
Dec-11-24 | Reiterated | JP Morgan | Overweight |
Nov-20-24 | Reiterated | Pivotal Research Group | Buy |
Oct-18-24 | Reiterated | Needham | Buy |
Oct-18-24 | Reiterated | Oppenheimer | Outperform |
Oct-18-24 | Reiterated | Pivotal Research Group | Buy |
Oct-16-24 | Reiterated | Loop Capital | Buy |
Oct-11-24 | Reiterated | Guggenheim | Buy |
Oct-10-24 | Reiterated | Morgan Stanley | Overweight |
Oct-10-24 | Reiterated | Oppenheimer | Outperform |
Oct-07-24 | Downgrade | Barclays | Equal Weight → Underweight |
Oct-07-24 | Upgrade | Piper Sandler | Neutral → Overweight |
Oct-01-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Sep-05-24 | Initiated | China Renaissance | Hold |
Aug-30-24 | Reiterated | Pivotal Research Group | Buy |
Jul-17-24 | Reiterated | Guggenheim | Buy |
Jul-16-24 | Reiterated | The Benchmark Company | Sell |
Jul-15-24 | Reiterated | BofA Securities | Buy |
Jul-12-24 | Reiterated | JP Morgan | Overweight |
Jul-10-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-09-24 | Reiterated | TD Cowen | Buy |
Jul-02-24 | Reiterated | Argus | Buy |
May-28-24 | Reiterated | Evercore ISI | Outperform |
Apr-19-24 | Downgrade | Canaccord Genuity | Buy → Hold |
Apr-19-24 | Upgrade | Needham | Hold → Buy |
Apr-19-24 | Reiterated | Pivotal Research Group | Buy |
Apr-15-24 | Reiterated | Deutsche Bank | Hold |
Apr-12-24 | Reiterated | Morgan Stanley | Overweight |
Apr-12-24 | Reiterated | Piper Sandler | Neutral |
Apr-05-24 | Reiterated | Pivotal Research Group | Buy |
Mar-25-24 | Reiterated | Citigroup | Neutral |
Mar-12-24 | Reiterated | Jefferies | Buy |
Mar-11-24 | Reiterated | Oppenheimer | Outperform |
Jan-30-24 | Downgrade | Seaport Research Partners | Buy → Neutral |
Jan-25-24 | Upgrade | DZ Bank | Hold → Buy |
Jan-24-24 | Reiterated | BMO Capital Markets | Outperform |
Jan-24-24 | Reiterated | BofA Securities | Buy |
Jan-24-24 | Reiterated | Canaccord Genuity | Buy |
Jan-24-24 | Reiterated | Evercore ISI | Outperform |
Jan-24-24 | Reiterated | Goldman | Neutral |
Jan-24-24 | Reiterated | Guggenheim | Buy |
Jan-24-24 | Reiterated | JP Morgan | Overweight |
Jan-24-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Jan-24-24 | Upgrade | Macquarie | Neutral → Outperform |
Jan-24-24 | Reiterated | Morgan Stanley | Overweight |
Jan-24-24 | Reiterated | Oppenheimer | Outperform |
Jan-24-24 | Reiterated | Piper Sandler | Neutral |
Jan-24-24 | Reiterated | Pivotal Research Group | Buy |
Jan-24-24 | Reiterated | Redburn Atlantic | Buy |
Jan-24-24 | Reiterated | Robert W. Baird | Outperform |
Jan-24-24 | Reiterated | TD Cowen | Outperform |
Jan-24-24 | Reiterated | UBS | Buy |
Jan-24-24 | Reiterated | Wells Fargo | Overweight |
Sep-18-23 | Reiterated | Evercore ISI | Outperform |
Aug-25-23 | Upgrade | Loop Capital | Hold → Buy |
Jul-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jul-17-23 | Reiterated | Deutsche Bank | Buy |
Jul-13-23 | Reiterated | JP Morgan | Overweight |
Jul-12-23 | Reiterated | UBS | Buy |
Jul-05-23 | Upgrade | Goldman | Sell → Neutral |
Jun-29-23 | Reiterated | Citigroup | Buy |
Jun-28-23 | Reiterated | Oppenheimer | Outperform |
Jun-13-23 | Reiterated | BofA Securities | Buy |
Jun-13-23 | Reiterated | Guggenheim | Buy |
Apr-19-23 | Reiterated | Deutsche Bank | Buy |
Apr-19-23 | Reiterated | JP Morgan | Overweight |
Apr-19-23 | Reiterated | Jefferies | Buy |
Apr-19-23 | Reiterated | Piper Sandler | Neutral |
Apr-19-23 | Reiterated | Pivotal Research Group | Buy |
Apr-19-23 | Reiterated | Rosenblatt | Neutral |
Apr-19-23 | Upgrade | UBS | Neutral → Buy |
Apr-11-23 | Resumed | Robert W. Baird | Neutral |
Jan-23-23 | Reiterated | Argus | Buy |
Jan-20-23 | Reiterated | Canaccord Genuity | Buy |
Jan-20-23 | Reiterated | Deutsche Bank | Buy |
Jan-20-23 | Reiterated | Evercore ISI | Outperform |
Jan-20-23 | Reiterated | Goldman | Sell |
Jan-20-23 | Reiterated | Guggenheim | Buy |
Jan-20-23 | Reiterated | Jefferies | Buy |
Jan-20-23 | Reiterated | MoffettNathanson | Market Perform |
Jan-20-23 | Reiterated | Oppenheimer | Outperform |
Jan-20-23 | Reiterated | Piper Sandler | Neutral |
Jan-20-23 | Reiterated | Pivotal Research Group | Buy |
Jan-20-23 | Reiterated | Robert W. Baird | Neutral |
Jan-20-23 | Reiterated | The Benchmark Company | Sell |
Jan-20-23 | Reiterated | Wedbush | Outperform |
Jan-20-23 | Reiterated | Wolfe Research | Outperform |
Jan-12-23 | Upgrade | Jefferies | Hold → Buy |
Jan-04-23 | Initiated | New Street | Neutral |
Dec-29-22 | Upgrade | CFRA | Sell → Buy |
Dec-14-22 | Reiterated | Jefferies | Hold |
Dec-09-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Jun-14-22 | Downgrade | The Benchmark Company | Hold → Sell |
Jun-10-22 | Downgrade | Goldman | Neutral → Sell |
May-16-22 | Upgrade | Wedbush | Neutral → Outperform |
Apr-21-22 | Downgrade | DZ Bank | Buy → Hold |
Apr-21-22 | Downgrade | Edward Jones | Buy → Hold |
Apr-20-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
Apr-20-22 | Downgrade | BofA Securities | Buy → Underperform |
Apr-20-22 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-20-22 | Upgrade | Needham | Underperform → Hold |
Apr-20-22 | Downgrade | Oppenheimer | Outperform → Perform |
Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Apr-20-22 | Downgrade | Pivotal Research Group | Buy → Sell |
Apr-20-22 | Downgrade | Stifel | Buy → Hold |
Apr-20-22 | Downgrade | UBS | Buy → Neutral |
Apr-20-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-19-22 | Initiated | Rosenblatt | Neutral |
Mar-09-22 | Upgrade | Wedbush | Underperform → Neutral |
Jan-31-22 | Upgrade | Citigroup | Neutral → Buy |
Jan-31-22 | Upgrade | Edward Jones | Hold → Buy |
Jan-24-22 | Downgrade | Jefferies | Buy → Hold |
Jan-21-22 | Reiterated | BMO Capital Markets | Outperform |
Jan-21-22 | Reiterated | BofA Securities | Buy |
Jan-21-22 | Reiterated | Canaccord Genuity | Buy |
Jan-21-22 | Reiterated | Cowen | Outperform |
Jan-21-22 | Reiterated | Deutsche Bank | Hold |
Jan-21-22 | Reiterated | Goldman | Neutral |
Jan-21-22 | Reiterated | Guggenheim | Buy |
Jan-21-22 | Reiterated | JP Morgan | Overweight |
Jan-21-22 | Reiterated | MoffettNathanson | Neutral |
Jan-21-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
Jan-21-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jan-21-22 | Reiterated | Oppenheimer | Outperform |
Jan-21-22 | Reiterated | Piper Sandler | Overweight |
Jan-21-22 | Reiterated | Pivotal Research Group | Buy |
Jan-21-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
Jan-21-22 | Reiterated | Stifel | Buy |
Jan-21-22 | Upgrade | The Benchmark Company | Sell → Hold |
Jan-21-22 | Downgrade | Truist | Buy → Hold |
Jan-21-22 | Reiterated | UBS | Buy |
Jan-21-22 | Reiterated | Wolfe Research | Outperform |
Dec-15-21 | Reiterated | The Benchmark Company | Sell |
Oct-20-21 | Downgrade | Deutsche Bank | Buy → Hold |
Oct-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
Sep-29-21 | Reiterated | The Benchmark Company | Sell |
Sep-13-21 | Initiated | Goldman | Neutral |
Sep-08-21 | Reiterated | JP Morgan | Overweight |
Sep-07-21 | Reiterated | Atlantic Equities | Overweight |
Jul-21-21 | Reiterated | Credit Suisse | Outperform |
Jul-21-21 | Reiterated | Deutsche Bank | Buy |
Jul-21-21 | Reiterated | JP Morgan | Overweight |
Jul-21-21 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-21-21 | Reiterated | Stifel | Buy |
Jun-25-21 | Upgrade | Credit Suisse | Neutral → Outperform |
Jun-25-21 | Initiated | Edward Jones | Hold |
May-19-21 | Resumed | Jefferies | Buy |
Apr-21-21 | Resumed | Oppenheimer | Outperform |
Apr-21-21 | Reiterated | Pivotal Research Group | Buy |
Apr-21-21 | Upgrade | Stifel | Hold → Buy |
Apr-06-21 | Resumed | Evercore ISI | Outperform |
Apr-01-21 | Initiated | Piper Sandler | Overweight |
Mar-25-21 | Reiterated | The Benchmark Company | Sell |
Mar-23-21 | Upgrade | Argus | Hold → Buy |
Jan-21-21 | Upgrade | DZ Bank | Hold → Buy |
Jan-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
Jan-20-21 | Reiterated | Pivotal Research Group | Buy |
Jan-20-21 | Reiterated | The Benchmark Company | Sell |
Jan-20-21 | Upgrade | UBS | Neutral → Buy |
Jan-20-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Oct-21-20 | Reiterated | BMO Capital Markets | Outperform |
Oct-21-20 | Reiterated | Bernstein | Outperform |
Oct-21-20 | Reiterated | Jefferies | Buy |
Oct-21-20 | Reiterated | Morgan Stanley | Overweight |
Oct-21-20 | Reiterated | Oppenheimer | Outperform |
Oct-21-20 | Reiterated | Piper Sandler | Overweight |
Oct-21-20 | Reiterated | Pivotal Research Group | Buy |
Oct-21-20 | Reiterated | RBC Capital Mkts | Outperform |
Oct-21-20 | Reiterated | The Benchmark Company | Sell |
Oct-21-20 | Reiterated | Wedbush | Underperform |
Oct-21-20 | Reiterated | Wells Fargo | Equal Weight |
Oct-16-20 | Reiterated | Morgan Stanley | Overweight |
Oct-15-20 | Reiterated | Canaccord Genuity | Buy |
Oct-14-20 | Reiterated | Goldman | Buy |
Oct-07-20 | Reiterated | Pivotal Research Group | Buy |
Sep-28-20 | Reiterated | The Benchmark Company | Sell |
Sep-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-09-20 | Resumed | Raymond James | Mkt Perform |
Sep-04-20 | Reiterated | The Benchmark Company | Sell |
Jul-29-20 | Reiterated | Loop Capital | Buy |
View All
Netflix Inc Stock (NFLX) Latest News
Mn Services Vermogensbeheer B.V. Sells 12,400 Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
David J Yvars Group Increases Stock Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Stock Movers: Circle, Marvell, Netflix - Bloomberg.com
Netflix, Inc. (NASDAQ:NFLX) Shares Sold by Trust Point Inc. - MarketBeat
Netflix adds live TV broadcasts and sports in France from TF1 - Los Angeles Times
Sowell Financial Services LLC Sells 1,002 Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix Dips Its Toe Into Old-Fashioned TV With TF1 Deal - The New York Times
New Season Of Netflix Hit Show ‘Somebody Feed Phil’ Inspires Travel Joy - Forbes
Netflix quietly slides into live TV business via partnership with France's TF1 (NFLX:NASDAQ) - Seeking Alpha
Netflix Stock Analysis: Surging Towards 52-Week Highs, But Is It Overpriced? - Daily Chhattisgarh News
Why the Netflix Stock (NFLX) Rally Isn’t Done Yet - Yahoo Finance
Netflix, Inc. (NFLX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Netflix Crushed Traditional TV. Why the Streamer Now Wants a Piece of the Action. - Barron's
Netflix and France’s TF1 join forces as traditional TV struggles - Euronews.com
State of Alaska Department of Revenue Has $49.63 Million Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix, Inc. (NASDAQ:NFLX) Shares Purchased by LifeWealth Investments LLC - MarketBeat
Netflix Signs Distribution Partnership Deal With France's TF1 - MarketScreener
Roman Butler Fullerton & Co. Trims Stock Holdings in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Kingswood Wealth Advisors LLC Grows Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix (NFLX) Partners with French Network TF1 for Linear TV Content | NFLX Stock News - GuruFocus
Clarius Group LLC Cuts Stock Holdings in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix, Inc. (NASDAQ:NFLX) Shares Bought by Prosperity Wealth Management Inc. - MarketBeat
How Criterion turned its film archives into a streaming powerhouse - Fast Company
Global Trust Asset Management LLC Has $35,000 Stake in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix Adds Live TV Broadcasts, Sports From France’s TF1 - Bloomberg.com
842 Shares in Netflix, Inc. (NASDAQ:NFLX) Bought by Inscription Capital LLC - MarketBeat
TF1, Netflix Partner To Bring TF1 To Netflix Members In France - marketscreener.com
Netflix And TF1 Group Join Forces To Bring TF1 To Netflix Members In France - About Netflix
Netflix strikes landmark deal with France’s TF1 to show traditional TV - Financial Times
Hoey Investments Inc. Has $223,000 Stock Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
News | Netflix selects Las Vegas Strip as third retail entertainment venue - CoStar
“Netflix House” to open in the fall at King of Prussia mall in Pennsylvania - CBS News
Netflix is letting fans step into their favorite shows with new themed ‘houses’ - San Francisco Chronicle
'My Brilliant Career' Series Adaptation Now in Production in South Australia for Netflix - About Netflix
Netflix Sets Australian Series Adaptation of ‘My Brilliant Career’ - Variety
Netflix House Dallas teases attraction lineup, launch update - Dallas News
Netflix (NFLX) Sees Bearish Option Activity as Shares Inch Highe - GuruFocus
Land of the Lost Reboot in the Works at Netflix - Yahoo
‘Land of the Lost’ Reboot Eyed at Netflix - The Hollywood Reporter
'Netflix House' coming to Dallas and Philly in late 2025; Vegas venue planned for 2027 (NFLX:NASDAQ) - Seeking Alpha
Netflix House to open in Philadelphia and Dallas in late 2025 By Investing.com - Investing.com Nigeria
‘Land Of The Lost’ Series Reboot In Works At Netflix From Legendary Television - Deadline
Joe Forte & Meg LeFauve’s Story House Inks Multi-Year Film Deal With Netflix - Deadline
Streaming surpasses broadcast and cable TV viewing in US for first time - MarketScreener
Netflix is setting its sights on the theme-park world, after already taking over TV - MarketWatch
Netflix Stock Gains 37% YTD, Can the Rally Continue? - MSN
Netflix House offers sneak peek at upcoming attractions in North Texas location - WFAA
Netflix Stock Gains 37% YTD, Can The Rally Continue? - Barchart.com
“Ozark Meets Outer Banks”: ‘The Waterfront’ Is Netflix’s New Crime Drama Series Based on True Events - cosmopolitan.com
YouTube’s Neal Mohan Fires Back at Netflix CEO’s “Killing Time” Dig - Adweek
Netflix Stock (NFLX) Analysis: Price Rebounds Today, Key Levels for Traders - Daily Chhattisgarh News
Netflix Inc Stock (NFLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Netflix Inc Stock (NFLX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
KILGORE LESLIE J | Director |
Jun 05 '25 |
Option Exercise |
287.61 |
652 |
187,523 |
36,048 |
KILGORE LESLIE J | Director |
Jun 05 '25 |
Sale |
1,251.64 |
652 |
816,070 |
35,396 |
MATHER ANN | Director |
Jun 05 '25 |
Option Exercise |
344.10 |
1,090 |
375,073 |
1,090 |
MATHER ANN | Director |
Jun 05 '25 |
Sale |
1,250.00 |
1,090 |
1,362,500 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):